Results 81 to 90 of about 72,300 (203)

Fluoroquinolones inhibit HCV by targeting its helicase

, 2012
Background: HCV has infected \u3e170 million individuals worldwide. Effective therapy against HCV is still lacking and there is a need to develop potent drugs against the virus.
Ali, Syed H., Siddiqui, Sammer, Kazmi, Shahana U., Khan, Irfan A., Rehmani, Sadiq   +4 more
core  

Fluoroquinolones for treating tuberculosis

, 2008
Background: Fluoroquinolones are sometimes used to treat multiple-drug-resistant and drug-sensitive tuberculosis. The effects of fluoroquinolones in tuberculosis regimens need to be assessed.
Ziganshina, Lilia E., Squire, Bertie
core   +1 more source

Fluoroquinolones for treating tuberculosis (presumed drug-sensitive). [PDF]

, 2013
Currently the World Health Organization only recommend fluoroquinolones for people with presumed drug-sensitive tuberculosis (TB) who cannot take standard first-line drugs.
Ziganshina L., Titarenko A., Davies G.
core  

Fluoroquinolones (FQs) effects on enterocytes and lymphocytes.

, 2003
The aim was to study fluoroquinolones intestinal concentrations and their potential interference with cells. Our preliminary results indicate that fluoroquinolones present different pharmacokinetic properties in relation to intestianal concentrations and
BERTAZZONI MINELLI, Elisa, BENINI, Anna, DORIA, Denise, FRANCESCHETTI, Paola, FRACASSO, Maria Enrica   +4 more
core   +1 more source

Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance

Infection and Drug Resistance, 2018
Mohamed Abdo Rizk,1,2 Mahmoud AbouLaila,3 Shimaa Abd El-Salam El-Sayed,1,4 Azirwan Guswanto,1,5 Naoaki Yokoyama,1 Ikuo Igarashi1 1National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada‑Cho ...
Rizk MA, AbouLaila M, El-Sayed SAE, Guswanto A, Yokoyama N, Igarashi I   +5 more
doaj  

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa

Infection and Drug Resistance, 2019
Xinyuan Feng,1,* Zhiqi Zhang,2,* Xiaoxia Li,3 Yan Song,3 Jianbang Kang,3 Donghong Yin,3 Yating Gao,3 Nan Shi,1 Jinju Duan3 1Department of Pharmacy, School of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China ...
Feng X, Zhang Z, Li X, Song Y, Kang J, Yin D, Gao Y, Shi N, Duan J   +8 more
doaj  

The New Fluoroquinolones: A Critical Review

, 2016
OBJECTIVE: This paper reviews the literature available on the new fluoroquinolones – clinafloxacin, gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin, sparfloxacin and trovafloxacin – to compare these agents with each other and contrast them with ...
Karlowsky, James A, Zhanel, George G, Hoban, Daryl J, Gin, Alfred S, Walkty, Andrew, Vercaigne, Lavern, Embil, John   +6 more
core   +1 more source

The association between oral fluoroquinolones and incident seizure event

, 2014
BACKGROUND: Fluoroquinolones are a class of antibiotics prescribed for various infections. Several case reports have indicated the potential association between the use of oral fluoroquinolones and the development of incident seizure event.
Chan, EW, Chui, SLC, Wong, ICK
core   +1 more source

Allergies et effets indésirabtes dus aux fluoroquinolones [Allergies and adverse events associated with fluoroquinolones]

, 2015
The prescription ot fluoroquinolones has been constantly increasing over the past decade. consequently, an increasing number of hyper-sensitivity reactions and adverse events have been reported.
Harr, T., Emonet, S., Muller, Y., Andrey, D., Spoerl, D.   +4 more
core   +1 more source

Topical fluoroquinolones for eye and ear

, 2007
Topical fluoroquinolones are now available for use in the eye and ear. Their broad spectrum of activity includes the common eye and ear pathogens Staphylococcus aureus and Pseudomonas aeruginosa.
Berke, Ethan M., Morden, Nancy E.
core